BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11295596)

  • 1. Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents.
    Nelson WG; Wilding G
    Urology; 2001 Apr; 57(4 Suppl 1):56-63. PubMed ID: 11295596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of prostate cancer: current status and future directions.
    Lieberman R
    Cancer Metastasis Rev; 2002; 21(3-4):297-309. PubMed ID: 12549768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective estrogen receptor modulators for the chemoprevention of prostate cancer.
    Steiner MS; Raghow S; Neubauer BL
    Urology; 2001 Apr; 57(4 Suppl 1):68-72. PubMed ID: 11295598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
    Lieberman R
    Urology; 2001 Aug; 58(2 Suppl 1):83-90. PubMed ID: 11502457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in prostate cancer chemoprevention: modulators of promotion and progression.
    Lieberman R; Bermejo C; Akaza H; Greenwald P; Fair W; Thompson I
    Urology; 2001 Dec; 58(6):835-42. PubMed ID: 11744441
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospects for chemoprevention of cancer.
    Tamimi RM; Lagiou P; Adami HO; Trichopoulos D
    J Intern Med; 2002 Apr; 251(4):286-300. PubMed ID: 11952879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of prostate cancer prevention.
    Brawley OW; Barnes S; Parnes H
    Ann N Y Acad Sci; 2001 Dec; 952():145-52. PubMed ID: 11795434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of prostate cancer.
    Kucuk O
    Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention of prostate cancer. Current status].
    Schmitz-Dräger BJ; Lümmen G; Schäfer RM
    Urologe A; 2007 Jun; 46(6):611-5. PubMed ID: 17483928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants for prostate cancer chemoprevention: challenges and opportunities.
    Thapa D; Ghosh R
    Biochem Pharmacol; 2012 May; 83(10):1319-30. PubMed ID: 22248733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
    Canby-Hagino ED; Thompson IM
    Nat Clin Pract Oncol; 2005 May; 2(5):255-61. PubMed ID: 16264961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agents in development for prostate cancer prevention.
    Nelson WG
    Expert Opin Investig Drugs; 2004 Dec; 13(12):1541-54. PubMed ID: 15566312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic prevention studies of prostate cancer.
    Djavan B; Zlotta A; Schulman C; Teillac P; Iversen P; Boccon Gibod L; Bartsch G; Marberger M
    J Urol; 2004 Feb; 171(2 Pt 2):S10-3; discussion S13-4. PubMed ID: 14713746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoprevention of prostate cancer].
    Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
    Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.